secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2022-05-24T23:59:59+00:00
Accession:  0000950170-22-010535
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director and Head of Strategic Partnerships Saiid Zarrabian departs Kintara; receives $213,750 severance
--------------------------------------------------------------------------------

- Zarrabian steps down from Board and Head of Strategic Partnerships effective May 23, 2022 by mutual agreement, not due to disagreements.
- Severance includes nine months base salary totaling $213,750 paid in installments, plus $24,826.67 one-time bonus.
- Stock options accelerated: 2,517,713 vested (including 6 months service credit); 754,188 unvested options forfeited.
- Healthcare and life insurance premiums reimbursed for up to nine months; non-solicitation covenant applies for 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017022010535/0000950170-22-010535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017022010535/ktra-20220520.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-010535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer